
At Philips' 2026 Annual General Meeting, shareholders approved all proposals, including the reappointment of Roy Jakobs as President, CEO, and Chairman. John DeFord was appointed as a new member of the Supervisory Board, bringing expertise in MedTech innovation and regulation. The reappointments of other board members ensure continuity as Philips advances its strategic goals. This leadership stability supports Philips' focus on innovation and profitable growth in health technology.